Local Cerebral Blood Flow and Its Response to Intravenous Levodopa in Progressive Supranuclear Palsy
Authors:
- Yasuo FukuuchiYFYasuo Fukuuchi
- Tamotsu ShinoharaTSTamotsu Shinohara
- Shigeru NogawaSNShigeru Nogawa
- Kazushi TakahashiKTKazushi Takahashi
- 1 July 1992
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 49 (7) , 725-730
Abstract
• The local cerebral blood flow (LCBF) at steady state and after the intravenous administration of levodopa (1 mg/kg) was measured by the xenon-enhanced computed tomographic method in six patients with progressive supranuclear palsy (PSP) and in nine patients with idiopathic Parkinson's disease. The baseline LCBF values in most brain regions in patients with PSP were lower than those in patients with Parkinson's disease, and hyperfrontality of the LCBF was lost. In patients with Parkinson's disease, the injection of levodopa markedly increased LCBF, especially in the striatum, thalamus, and internal capsule (approximately 40%). In patients with PSP, however, levodopa did not increase the LCBF in all brain regions examined. The LCBF increases after the administration of levodopa in patients with Parkinson's disease may be secondary to metabolic activation of the dopaminergic system. The different LCBF responses to levodopa between patients with PSP and those with Parkinson's disease may reflect differences in pathologic features, such as in the degree of preservation of nigrostriatal dopaminergic neurons and the distribution and density of dopamine receptors, and are also related to the clinical effectiveness of levodopa therapy.Keywords
This publication has 9 references indexed in Scilit:
- Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomographyAnnals of Neurology, 1988
- Nonoxidative Glucose Consumption During Focal Physiologic Neural ActivityScience, 1988
- The clinical features and natural history of the Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)Neurology, 1986
- Progressive supranuclear palsy: Clinical features and response to treatment in 16 patientsAnnals of Neurology, 1983
- The distribution of alterations in energy metabolism in the rat brain produced by apomorphineBrain Research, 1982
- Cerebral circulatory and metabolic effects of piribedilEuropean Journal of Pharmacology, 1980
- INFLUENCE OF DOPAMINE AND NORADRENALINE ON ISOLATED CEREBRAL ARTERIES OF THE DOGBritish Journal of Pharmacology, 1976
- The `subcortical dementia' of progressive supranuclear palsyJournal of Neurology, Neurosurgery & Psychiatry, 1974
- Measurement of regional cerebral blood flow with antipyrine-14C in awake cats.Journal of Applied Physiology, 1969